Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Mucormycosis involving paranasal sinuses in a post-COVID-19 patient with an uncontrolled diabetes-A rare presentation in an ongoing pandemic

Novelesh Bachchan, Sankalp Yadav, Gautam Rawal, Pallawi Rai

Plant sap keratouveitis

Vasantha N, Theertha Rajesh, Mohammed Haneef, Haleema A, Parvathy P S

Comparision of effectiveness of topical acetic acid instillation with topical antibiotics in madical management of tubotympanic chronic suppurative otitis media (CSOM)

Paridhi Goyal, Jasmin Mehta, Udit Chawda, Sushil Jha

Seroprevalence of HIV, Hepatitis B and Hepatitis C infections in cataract surgery patients

Potluri Ravikiran, Uppala Nageswara Rao

Pilomatricoma: A diagnostic challenge both for the clinician and cytopathologist

Sharmila Dudani, Rajendra Maskara, Navneet Nath

Mucormycosis uncommon encounters: Pediatric and geriatric perspectives in a case report

Kumar Saket, Manjunath Vijapur, Priya Jha, Vasant Kattimani

Develop a validated anesthesia quality assessment to evaluate patients postoperatively

Parakkamodom S, Vichitvejpaisal P, Noitasaeng P, Udompunturak S, Amornyotin S

Lung abscess with metastatic brain abscess- A case report

Vishnukanth Govindaraj, Balla Nagamalli Kumar, Dharm Prakash Dwivedi, Pratap Upadhya

Novel corona virus and its druggable targets

Chiragkumar J. Gohil, Malleshappa N. Noolvi